3Tillett WS, Francis T. Serological reactions in pneumonia with a nonprotein somatic fraction of the pneumococ- cus. J Exp Med, 1930, 52:561 -571.
4YIN W H, CHEN J W, JEN H L, et al. Independent prognostic value of elevated high - sensitivity C - re - active protein in chronic heart failure[J].Am Heart J,2004, 147:931 - 938.
6Zwaka TP, Hombach V, Torzewski J, C- reactive protein medi- ated low density lipoprotein uptake by macrophages: implica- tions for atherosclerosis[J]. Circulation, 2001, 103(7): 1194- 1197.
7Torzewski J, Torzewski M, Bowyer protein frequently colocalizes with complex in the intima of DE, et, al. C-reactive the terminal comple- lesions of human coronary arteries[J] Vasc Biol, 1998, 18(9): 1386 - 1392. early atherosclerotic Arterioseler Thromb.
8Li JJ, Fang CH. C-reactive protein is not only inflammatory marker but also a direct cause of car- diovascular disease[J]. Med Hypotheses, 2004, 62(4): 499- 506.
10Verma, S, Wang CH, Li SH, et al.A self-fulfilling prophecy: C - reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002, 106 (8): 913 -919.
4Alpert J S, Thygesen K, Antman E, et al. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol , 2000,36:959.
5Feruson JL, Beckett GJ, Stoddart M, et al. Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troportia, increases the apparent incidence of infarction. Heart,2002,88(4) :343.
6Meier MA, Albar WH, Cooper JV, et al. The new definition of myocardial infarction : diagnostic and prognostic implications in patients with acute coronary syndromes. Arch Intern Med, 2002,162(14): 1585.
7Sousa E, Costa MA, Sousa A, et al. Two- year angiographic and intravascular ultrasound follow- up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation, 2003,107:381.
8Grube E , Silber S, Eugen HK, et al. Six- and twelve- month results from a randomized, double- blind trial on a slow- release paclitaxel - eluting stent for de novo coronary lesions. Circulation,2003,107 : 38.
9Braunwald E, Antman EM, Califf RM, et al. Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation, 2002, 106:1893.
10Du Clos TW.Function of C-reactive protein[].Annals of Medicine.2000
4Nissen SE,Tuzcu EM,Schoenhagen P,et al.Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary aherosclerosis:A Randomized controlled trial[J].JAMA,2004,291:1071-1080.
5Heart Protection Study Collaborative Group.MRC/BHF Heart Protection study of cholesterol lowering with simvastatin in 20,536 highrisk individuals:A randomizedplacebo-controlled trial[J].Lancet,2002,360(9326):7.
6Biasucci LM,Liuzzo G,Grillo RL,et al.Elevated levels of C-reactive proteinat discharge in patient with unstable angina pectoris recurrent instability[J].Circulation,1999,99:2079-2084.
7Karaca I,Hkay E,Akbulut M,et al.Atorvastatia affects C-reactive protein levels in patients with coronary artery disease[J].Curr Med Res Opin,2003,19(3):187.
